Literature DB >> 21703406

Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury.

Zaher A Radi1, Petra H Koza-Taylor, Rosonald R Bell, Leslie A Obert, Herbert A Runnels, Jean S Beebe, Michael P Lawton, Seth Sadis.   

Abstract

Macrophage colony-stimulating factor (M-CSF) is a hematopoietic growth factor that is responsible for the survival and proliferation of monocytes and the differentiation of monocytes into macrophages, including Kupffer cells (KCs) in the liver. KCs play an important role in the clearance of several serum enzymes, including aspartate aminotransferase and creatine kinase, that are typically elevated as a result of liver or skeletal muscle injury. We used three distinct animal models to investigate the hypothesis that increases in the levels of serum enzymes can be the result of decreases in KCs in the apparent absence of hepatic or skeletal muscle injury. Specifically, neutralizing M-CSF activity via a novel human monoclonal antibody reduced the CD14(+)CD16(+) monocyte population, depleted KCs, and increased aspartate aminotransferase and creatine kinase serum enzyme levels in cynomolgus macaques. In addition, the treatment of rats with clodronate liposomes depleted KCs and led to increased serum enzyme levels, again without evidence of tissue injury. Finally, in the osteopetrotic (Csf1(op)/Csf1(op)) mice lacking functional M-CSF and having reduced levels of KCs, the levels of serum enzymes are higher than in wild-type littermates. Together, these findings support a mechanism for increases in serum enzyme levels through M-CSF regulation of tissue macrophage homeostasis without concomitant histopathological changes in either the hepatic or skeletal system.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703406      PMCID: PMC3123844          DOI: 10.1016/j.ajpath.2011.03.029

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  The macrophage scavenger receptor CD163.

Authors:  Babs O Fabriek; Christine D Dijkstra; Timo K van den Berg
Journal:  Immunobiology       Date:  2005       Impact factor: 3.144

2.  CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens.

Authors:  Karim Y Helmy; Kenneth J Katschke; Nick N Gorgani; Noelyn M Kljavin; J Michael Elliott; Lauri Diehl; Suzie J Scales; Nico Ghilardi; Menno van Lookeren Campagne
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

3.  CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor.

Authors:  E R Stanley; L J Guilbert; R J Tushinski; S H Bartelmez
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

4.  Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody.

Authors:  Suwen Wei; Daniel Lightwood; Heather Ladyman; Sue Cross; Helen Neale; Meryn Griffiths; Ralph Adams; Diane Marshall; Alastair Lawson; Andrew J McKnight; E Richard Stanley
Journal:  Immunobiology       Date:  2005       Impact factor: 3.144

5.  The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production.

Authors:  Machteld M J Polfliet; Babs O Fabriek; Wouter P Daniëls; Christine D Dijkstra; Timo K van den Berg
Journal:  Immunobiology       Date:  2006-07-24       Impact factor: 3.144

Review 6.  Kupffer cell complement receptor clearance function and host defense.

Authors:  D J Loegering
Journal:  Circ Shock       Date:  1986

7.  ISOENZYMIC SPECIFICITY OF IMPAIRED CLEARANCE IN MICE INFECTED WITH RILEY VIRUS.

Authors:  B W MAHY; K E ROWSON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

8.  Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion.

Authors:  Takashi Yamamoto; Chikako Kaizu; Takashi Kawasaki; Go Hasegawa; Hajime Umezu; Riuko Ohashi; Junko Sakurada; Shuying Jiang; Leonard Shultz; Makoto Naito
Journal:  Cell Tissue Res       Date:  2008-03-12       Impact factor: 5.249

9.  Several dehydrogenases and kinases compete for endocytosis from plasma by rat tissues.

Authors:  M K Bijsterbosch; A M Duursma; M J Smit; O J Bos; J M Bouma; M Gruber
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

10.  Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression.

Authors:  M Granado; A I Martín; T Priego; M A Villanúa; A López-Calderón
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

View more
  45 in total

1.  Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.

Authors:  William D Tap; Hans Gelderblom; Emanuela Palmerini; Jayesh Desai; Sebastian Bauer; Jean-Yves Blay; Thierry Alcindor; Kristen Ganjoo; Javier Martín-Broto; Christopher W Ryan; David M Thomas; Charles Peterfy; John H Healey; Michiel van de Sande; Heather L Gelhorn; Dale E Shuster; Qiang Wang; Antoine Yver; Henry H Hsu; Paul S Lin; Sandra Tong-Starksen; Silvia Stacchiotti; Andrew J Wagner
Journal:  Lancet       Date:  2019-06-19       Impact factor: 79.321

2.  The effect of statins on skeletal muscle function: the STOMP trial.

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.113

3.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

4.  Effect of removing Kupffer cells on nanoparticle tumor delivery.

Authors:  Anthony J Tavares; Wilson Poon; Yi-Nan Zhang; Qin Dai; Rickvinder Besla; Ding Ding; Ben Ouyang; Angela Li; Juan Chen; Gang Zheng; Clinton Robbins; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

Review 5.  Macrophages and therapeutic resistance in cancer.

Authors:  Brian Ruffell; Lisa M Coussens
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

6.  Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.

Authors:  K Masek-Hammerman; E Peeva; A Ahmad; S Menon; M Afsharvand; R Peng Qu; J B Cheng; J Syed; Y Zhan; S P O'Neil; S Pleasic-Williams; L A Cox; D Beidler
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

7.  Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Authors:  Brian Ruffell; Debbie Chang-Strachan; Vivien Chan; Alexander Rosenbusch; Christine M T Ho; Nancy Pryer; Dylan Daniel; E Shelley Hwang; Hope S Rugo; Lisa M Coussens
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

8.  Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice.

Authors:  Su Jin Kang; Beom Rak Choi; Seung Hee Kim; Hae Yeon Yi; Hye Rim Park; Chang Hyun Song; Sae Kwang Ku; Young Joon Lee
Journal:  Exp Ther Med       Date:  2017-02-08       Impact factor: 2.447

9.  Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.

Authors:  Avery Polk; Ye Lu; Tianjiao Wang; Erlene Seymour; Nathanael G Bailey; Jack W Singer; Philip S Boonstra; Megan S Lim; Sami Malek; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2016-06-22       Impact factor: 12.531

10.  Late Protective Effect of Netrin-1 in the Murine Acetaminophen Hepatotoxicity Model.

Authors:  Luqi Duan; Benjamin L Woolbright; Hartmut Jaeschke; Anup Ramachandran
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.